EYEPOINT PHARMACEUTICALS INC (EYPT)

US30233G2093 - Common Stock

11.87  +0.67 (+5.98%)

After market: 11.51 -0.36 (-3.03%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
46.02M41.40M36.94M34.44M20.37M
Cost Of Goods
4.63M8.33M8.18M5.82M2.69M
Gross Profit
41.39M33.08M28.76M28.61M17.68M
Operating Expenses
116.45M112.01M84.04M65.31M65.54M
Research and Development
64.66M49.64M28.50M17.42M15.37M
Selling, General, and Administrative Expenses
51.79M60.32M53.08M45.43M47.71M
Operating Income
-75.07M-78.94M-55.28M-36.70M-47.86M
Interest Income/Expense
5.70M-1.06M-5.21M-7.20M-5.12M
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
-1.35M-22.26M2.07M-1.50M-3.81M
Income Before Taxes
-70.71M-102.25M-58.42M-45.39M-56.79M
Income Tax
83.00KN/AN/AN/AN/A
Net Income
-70.80M-102.25M-58.42M-45.39M-56.79M
EBITDA
-74.60M-76.49M-52.51M-34.05M-45.26M
 
Per Share Data
EPS Diluted Total Ops
-1.82-2.74-2.03-3.54-5.44
Non GAAP EPS
-1.83-2.73-2.02-3.40-5.20
 
Statistics
Gross Profit Margin
89.93%79.90%77.86%83.07%86.79%
Profit Margin
-153.84%-246.98%-158.15%-131.79%-278.79%
Operating Profit Margin
-163.13%-190.68%-149.65%-106.56%-234.95%

All data in USD

Charts